Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
PHI’s Board of Directors proposes a Direct Issue of shares of 9.9 MSEK to Altium
PHI’s Board of Directors proposes a direct issue of 2 374 820 new shares to the Company’s largest shareholder, Altium S.A.
PHI endorses WFIRM as Finalist for NSF’s $160 Million Innovation Grant
PHI proudly stands behind the Wake Forest Institute for Regenerative Medicine (WFIRM) as they contend as a finalist in the National Science Foundation’s (NSF) Regional Innovation Engines competition, with a potential award of up to $160 million.
Recommended Vessel List
This is a list of cell culture vessels that have been thoroughly tested to ensure good image quality with the HoloMonitor system.
Notice of Annual General Meeting in Phase Holographic Imaging PHI AB
The shareholders of Phase Holographic Imaging PHI AB (publ), 556542-7811, are hereby invited to the annual general meeting on Friday 27 October 2023 at 13.00 at Scandic Star Hotel, Glimmervägen 5 in Lund.
The App Suite 4.0 with fluorescence software update
With the HoloMonitor App Suite 4.0 software update, we provide you with numerous enhancements to make your research smoother and more insightful. However, the highlight is the integration of fluorescence capture and analysis using the HoloMonitor M4 add-on fluorescence unit.
Interim Report 1 2023/24
During this past summer quarter, we made it our most prosperous Q1 quarter to date, characterized by sustained growth.
Fluorescence Capture Protocol
The Fluorescence Capture allows HoloMonitor M4FL to capture fluorescent images for further analysis in other HoloMonitor App Suite assays. Requires App Suite 4.0 or higher.
Notice that Interim Report 1 2023/24 will be published on September 20, 2023
Phase Holographic Imaging announces that the date for publication of Interim Report 1 2023/24 is September 20, 2023.
PHI AB annual general meeting moved to 27 October 2023
The PHI AB board has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023.
BioStock: PHI links up with two regenerative medicine networks
BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.